National Marrow Donor Program, Minneapolis, Minnesota; Hematology/Oncology/Blood and Marrow Transplant and Infectious Diseases; Nationwide Children's Hospital, Columbus, Ohio.
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Transplant Cell Ther. 2023 Dec;29(12):739-746. doi: 10.1016/j.jtct.2023.09.026. Epub 2023 Oct 5.
Here the proceedings from the Second Annual American Society for Transplantation and Cellular Therapy (ASTCT) and National Marrow Donor Program (NMDP) ACCESS Initiative are reviewed to inform the hematopoietic cell transplantation (HCT) and cellular therapy (CT) ecosystem about progress and direction of the collaborative. Highlights from the meeting, including updates on the progress of projects from the Awareness, Poverty, and Racial Inequity Committees, are presented. The ACCESS Initiative continues to evolve and will remain dependent on the HCT/CT ecosystem's continued dedication to reduce barriers and improve outcome disparities for all patients in need of HCT/CT.
现将第二届美国移植与细胞治疗学会 (ASTCT) 和全国骨髓供者计划 (NMDP) ACCESS 倡议年会的进展情况进行回顾,以便向造血细胞移植 (HCT) 和细胞治疗 (CT) 领域介绍合作的进展和方向。会议的重点内容包括意识、贫困和种族不平等委员会项目进展的最新情况。ACCESS 倡议在不断发展,仍将依赖于 HCT/CT 领域继续致力于减少障碍,改善所有需要 HCT/CT 的患者的结果差异。